AC Immune SA (ACIU) Stock: Buy, Sell, or Hold?
$2.14
-0.12 (-5.31%)
▼
5d:
+1.42%
30d:
-10.83%
90d:
-14.06%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (75%)
Quality Score
50/100
Position
OVERSOLD
30-Day Fair Range
$2.22 – $2.52
Position: OVERSOLD
Forward P/E & Valuation
3.8x
CHEAP
vs 10.7x historical avg
Wall Street Target
$8.44
+294.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.02 / $2.55
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ACIU shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When ACIU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$8.50
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$5.28
59.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ACIU is currently trading at $2.14, which is considered oversold relative to its 30-day fair value range of $2.22 to $2.52. From a valuation perspective, the stock is trading at a discount (Forward PE: 3.8) compared to its historical average (10.7). Remarkably, the market is currently pricing in an annual earnings decline of 29.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ACIU is showing sideways momentum. Immediate support is located at $2.02, while resistance sits at $2.55. Short-term momentum is weak, with the stock down 5.3% recently.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.44 (+294.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ACIU is showing sideways momentum. Immediate support is located at $2.02, while resistance sits at $2.55. Short-term momentum is weak, with the stock down 5.3% recently.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.44 (+294.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.22 -
$2.52
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
Trading Range & Key Levels
30-Day Trading Range
$2.22 -
$2.52
Current vs Trading Range
OVERSOLD
Support Level
$2.02
Resistance Level
$2.55
Current Trend
Sideways
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (44/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.3%)
- BULLISH: Trading 294.5% below Wall St target ($8.44)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
3.78
Wall Street Target
$8.44
(+294.5%)
Revenue Growth (YoY)
245.5%
Profit Margin
-181.9%
Valuation Discount vs History
-29.3% cheaper
PE vs Historical
3.8 vs 10.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-29.3%
(market-implied from PE analysis)
1-Year Target
$1.93
(-10%)
2-Year Target
$1.73
(-19%)
3-Year Target
$1.56
(-27%)
3-Yr Target (if PE normalizes)
(PE: 4→11)
$4.42
(+107%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 3.8 to 10.7
Stabilization Target:
$6.06
(+183.3%)
PE Expansion Potential:
+183.3%
Share ACIU Analysis
Share this live ACIU analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ACIU)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 9, 2026
Daily AI digest
AI Retail Discussion Summary:
Bullish sentiment dominates on StockTwits for $ACIU with no new news articles available.
Key Retail Themes:
Bullish outlook
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 8:07 PM ET
Data refreshes hourly during market hours. Next update: 9:07 PM
Data refreshes hourly during market hours. Next update: 9:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACIU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 37 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 31 SELL |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 41 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 39 SELL |
|
SYRE
Spyre Therapeutics Inc. |
STRONG BUY
18 analysts |
$122 | 44 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ACIU Research Pages
